RECURRENT NON-SMALL CELL LUNG CARCINOMA
Clinical trials for RECURRENT NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a new drug called sEphB4-HSA combined with standard chemotherapy in 61 people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The goal was to find the best dose and check for side effects. Whi…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for advanced lung cancer: adding targeted treatment may extend life
Disease control OngoingThis study tests whether adding local treatments like radiation or surgery to standard maintenance chemotherapy helps people with stage IV non-small cell lung cancer live longer without the disease getting worse. About 218 participants are randomly assigned to receive either chem…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 18, 2026 12:03 UTC